Literature DB >> 32062153

The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae.

Kimberly A Walker1, Virginia L Miller2.   

Abstract

For ∼30 years, two distinct groups of clinical isolates of Klebsiella pneumoniae have been recognized. Classical strains (cKp) are typically isolated from patients with some degree of immunocompromise and are not virulent in mouse models of infection whereas hypervirulent strains (hvKp) are associated with community acquired invasive infections and are highly virulent in mouse models of infection. Hyperproduction of capsule and a hypermucoviscous colony phenotype have been strongly associated with the hypervirulence of hvKp strains. Recent studies have begun to elucidate the relationship between capsule gene expression, hypermucoviscosity and hypervirulence. Additionally, genes associated with hyperproduction of capsule and hypermucoviscosity in hvKp strains have been identified in a few cKp isolates. However, it is not clear how the acquisition of these genes impacts the virulence of cKp isolates. A better understanding of the potential risks of these strains is particularly important given that many of them are resistant to multiple antibiotics, including carbapenems.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32062153      PMCID: PMC8121214          DOI: 10.1016/j.mib.2020.01.006

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  65 in total

1.  Homologous response regulators KvgA, KvhA and KvhR regulate the synthesis of capsular polysaccharide in Klebsiella pneumoniae CG43 in a coordinated manner.

Authors:  Ching-Ting Lin; Teng-Yi Huang; Wan-Chun Liang; Hwei-Ling Peng
Journal:  J Biochem       Date:  2006-07-27       Impact factor: 3.387

2.  Emergence of IMP-producing hypervirulent Klebsiella pneumoniae carrying a pLVPK-like virulence plasmid.

Authors:  Sohei Harada; Kotaro Aoki; Yoshikazu Ishii; Yuki Ohno; Akihiro Nakamura; Masaru Komatsu; Kazuhiro Tateda
Journal:  Int J Antimicrob Agents       Date:  2019-05-07       Impact factor: 5.283

3.  Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections.

Authors:  Matthew S Lawlor; Scott A Handley; Virginia L Miller
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

4.  Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ.

Authors:  R Wacharotayankun; Y Arakawa; M Ohta; K Tanaka; T Akashi; M Mori; N Kato
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  The rcsA gene of Klebsiella pneumoniae O1:K20 is involved in expression of the serotype-specific K (capsular) antigen.

Authors:  K L McCallum; C Whitfield
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

6.  EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB.

Authors:  O Lomovskaya; K Lewis; A Matin
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

7.  Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor.

Authors:  X Nassif; J M Fournier; J Arondel; P J Sansonetti
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae.

Authors:  Thomas A Russo; Ruth Olson; Ulrike Macdonald; Daniel Metzger; Lauren M Maltese; Eric J Drake; Andrew M Gulick
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

9.  Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Authors:  Victor L Yu; Dennis S Hansen; Wen Chien Ko; Asia Sagnimeni; Keith P Klugman; Anne von Gottberg; Herman Goossens; Marilyn M Wagener; Vicente J Benedi
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

10.  The Capsule Regulatory Network of Klebsiella pneumoniae Defined by density-TraDISort.

Authors:  Matthew J Dorman; Theresa Feltwell; David A Goulding; Julian Parkhill; Francesca L Short
Journal:  mBio       Date:  2018-11-20       Impact factor: 7.867

View more
  17 in total

1.  The KbvR Regulator Contributes to Capsule Production, Outer Membrane Protein Biosynthesis, Antiphagocytosis, and Virulence in Klebsiella pneumoniae.

Authors:  Li Xu; Meng Wang; Jie Yuan; Hui Wang; Moran Li; Fusheng Zhang; Yujiao Tian; Jing Yang; Jingjie Wang; Bei Li
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

2.  The Epidemiology of Invasive, Multipleantibiotic-resistant Klebsiella pneumoniae Infection in a Breeding Colony of Immunocompromised NSG Mice.

Authors:  Melissa I Stair; Sebastian E Carrasco; Damodaran Annamalai; Ellen B Jordan; Anthony Mannion; Yan Feng; Niora Fabian; Zhongming Ge; Sureshkumar Muthupalani; JoAnn Dzink-Fox; Marine Anais Krzisch; James G Fox
Journal:  Comp Med       Date:  2022-07-26       Impact factor: 1.565

3.  Whole Genome Characterization of the High-Risk Clone ST383 Klebsiella pneumoniae with a Simultaneous Carriage of blaCTX-M-14 on IncL/M Plasmid and blaCTX-M-15 on Convergent IncHI1B/IncFIB Plasmid from Egypt.

Authors:  Eva A Edward; Nelly M Mohamed; Azza S Zakaria
Journal:  Microorganisms       Date:  2022-05-26

4.  Unusual Hypermucoviscous Clinical Isolate of Klebsiella pneumoniae with No Known Determinants of Hypermucoviscosity.

Authors:  Tamal Dey; Ardhendu Chakrabortty; Aastha Kapoor; Anuja Warrier; Vijaya Lakshmi Nag; Karthikeyan Sivashanmugam; Manoharan Shankar
Journal:  Microbiol Spectr       Date:  2022-06-01

5.  Biofilm Production by Carbapenem-Resistant Klebsiella pneumoniae Significantly Increases the Risk of Death in Oncological Patients.

Authors:  Enea Gino Di Domenico; Ilaria Cavallo; Francesca Sivori; Francesco Marchesi; Grazia Prignano; Fulvia Pimpinelli; Isabella Sperduti; Lorella Pelagalli; Fabiola Di Salvo; Ilaria Celesti; Silvia Paluzzi; Carmelina Pronesti; Tatiana Koudriavtseva; Fiorentina Ascenzioni; Luigi Toma; Assunta De Luca; Andrea Mengarelli; Fabrizio Ensoli
Journal:  Front Cell Infect Microbiol       Date:  2020-12-10       Impact factor: 5.293

6.  A systematic analysis of hypermucoviscosity and capsule reveals distinct and overlapping genes that impact Klebsiella pneumoniae fitness.

Authors:  Laura A Mike; Andrew J Stark; Valerie S Forsyth; Jay Vornhagen; Sara N Smith; Michael A Bachman; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2021-03-15       Impact factor: 6.823

7.  The Epidemiology, Virulence and Antimicrobial Resistance of Invasive Klebsiella pneumoniae at a Children's Medical Center in Eastern China.

Authors:  Yang Li; Dan Li; Jian Xue; Xueqiang Ji; Xuejun Shao; Jie Yan
Journal:  Infect Drug Resist       Date:  2021-09-14       Impact factor: 4.003

8.  Molecular Epidemiology and Drug Resistant Mechanism of Carbapenem-Resistant Klebsiella pneumoniae in Elderly Patients With Lower Respiratory Tract Infection.

Authors:  Chunhong Shao; Wei Wang; Shuang Liu; Zhijun Zhang; Meijie Jiang; Fusen Zhang
Journal:  Front Public Health       Date:  2021-05-20

9.  A Sequence Type 23 Hypervirulent Klebsiella pneumoniae Strain Presenting Carbapenem Resistance by Acquiring an IncP1 bla KPC-2 Plasmid.

Authors:  Rushuang Yan; Ye Lu; Yiwei Zhu; Peng Lan; Shengnan Jiang; Jun Lu; Ping Shen; Yunsong Yu; Jiancang Zhou; Yan Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-06-01       Impact factor: 5.293

10.  An Assessment of Siderophore Production, Mucoviscosity, and Mouse Infection Models for Defining the Virulence Spectrum of Hypervirulent Klebsiella pneumoniae.

Authors:  Thomas A Russo; Ulrike MacDonald; Sidra Hassan; Ellie Camanzo; Francois LeBreton; Brendan Corey; Patrick McGann
Journal:  mSphere       Date:  2021-03-24       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.